TREACE MEDICAL CONCEPTS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.4 USD | +0.97% |
|
-5.20% | -18.43% |
| 03-25 | Treace Medical Concepts Treats 100,000 Patients With Lapiplasty Bunion Correction | MT |
| 02-27 | Transcript : Treace Medical Concepts, Inc., Q4 2023 Earnings Call, Feb 27, 2024 |
Chart calendar Treace Medical Concepts, Inc.
e1f255ea3cec6da1530d492d08cb.u8p5zmM42F3lUEmvEULNQS8qhTgxN6udnBTU43epZIQ.4ZAhmhpVgG6xMgbBVQ26eF5mzVBbWc7CxnfhjEGcIcHSh0C6LG2fOZYnBA~2046b8e124780503e63c583cd1162c3f
Upcoming events on Treace Medical Concepts, Inc.
Past events on Treace Medical Concepts, Inc.
| 27/02/2024 21:30 | Q4 2023 Earnings Call |
| 27/02/2024 21:05 | Q4 2023 Earnings Release |
| 31/01/2024 | ACFAS Scientific Conference |
| 09/01/2024 23:45 | JPMorgan Healthcare Conference - Fireside Chat |
| 14/11/2023 13:35 | Stifel Healthcare Conference - Fireside Chat |
| 09/11/2023 21:30 | Q3 2023 Earnings Call |
| 09/11/2023 21:05 | Q3 2023 Earnings Release |
| 21/09/2023 15:00 | American Orthopaedic Foot & Ankle Society Meeting - Robert Santrock |
| 12/09/2023 13:10 | Morgan Stanley Global Healthcare Conference |
| 16/08/2023 16:00 | UBS Genomics 2.0 and MedTech Innovations Summit |
| 08/08/2023 21:30 | Q2 2023 Earnings Call |
| 08/08/2023 21:05 | Q2 2023 Earnings Release |
| 23/05/2023 16:00 | Annual General Meeting |
| 10/05/2023 16:40 | Bank of America Healthcare Conference |
| 08/05/2023 21:30 | Q1 2023 Earnings Call |
| 08/05/2023 21:05 | Q1 2023 Earnings Release |
| 07/03/2023 21:30 | Q4 2022 Earnings Call |
| 07/03/2023 21:05 | Q4 2022 Earnings Release |
| 11/01/2023 15:30 | JP Morgan Healthcare Conference |
| 15/11/2022 14:10 | Stifel Healthcare Conference - Fireside Chat |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 57,4 | 94,4 93,3 1.15% | 142 137 3.51% | 187 185 0.99% | 223 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -12,4 -8,45 -46.91% | -23,7 -36,5 35.1% | -24,4 -31,8 23.33% | -30,6 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -16,5 -10,2 -61.14% | -34,8 -38,3 8.96% | -51,4 -50,3 -2.26% | -57,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -20,6 -14,2 -44.73% | -42,8 -47,6 10.05% | -49,5 -49,7 0.33% | -56,7 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -20,7 -14,2 -46.07% | -42,8 -47,6 10.05% | -49,5 -49,7 0.32% | -56,7 |
|
EPS USD | Released Forecast Spread | -0,12 | -0,43 -0,30 -45.63% | -0,77 -0,84 8.7% | -0,81 -0,80 -1.24% | -0,93 |
| Announcement Date | 30/03/21 | 03/03/22 | 07/03/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 33,4 32,3 3.63% | 29,0 26,0 11.58% | 30,0 28,6 4.66% | 33,1 30,1 9.94% | 49,8 44,8 11.01% | 42,2 39,2 7.51% | 42,0 40,8 2.71% | 40,8 42,1 -3.08% | 62,2 60,2 3.29% | 49,1 | 49,8 | 49,8 | 73,9 | 58,2 |
|
EBITDA Million USD | Released Forecast Spread | -4,03 1,10 -466.18% | -6,35 -10,1 37.1% | -9,42 -11,5 18.1% | -8,22 -13,7 40.04% | 0,29 -7,90 103.62% | -10,0 -10,0 -0.05% | -7,75 -12,1 36.08% | -9,24 -11,5 19.75% | 2,63 3,48 -24.54% | -10,7 | -8,00 | -8,70 | 5,98 | -4,85 |
|
EBIT Million USD | Released Forecast Spread | -5,60 0,75 -846.27% | -8,10 -8,85 8.52% | -11,9 -10,7 -11.87% | -11,3 -14,9 24.21% | -3,50 -7,43 52.96% | -13,8 -12,5 -10.6% | -13,1 -14,9 12.68% | -17,8 -16,2 -10.05% | -6,78 -5,66 -19.9% | -19,0 | -16,3 | -17,1 | -4,10 | -16,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,62 -0,50 -1223.8% | -9,04 -9,35 3.36% | -17,2 -11,0 -57.15% | -12,1 -16,0 24.01% | -4,41 -8,43 47.68% | -13,5 -13,7 1.51% | -12,3 -14,7 16.49% | -17,5 -16,5 -6.03% | -6,28 -6,88 8.64% | -19,1 | -16,6 | -17,1 | -3,37 | -16,3 |
|
Net income Million USD | Released Forecast Spread | -6,62 -0,52 -1172.88% | -9,04 -10,6 15% | -17,2 -11,4 -51.4% | -12,1 -16,0 24.01% | -4,41 -8,43 47.68% | -13,5 -13,7 1.51% | -12,3 -14,7 16.49% | -17,5 -16,5 -6.03% | -6,28 -6,88 8.64% | -19,1 | -16,6 | -17,1 | -3,37 | -16,3 |
|
EPS USD | Released Forecast Spread | -0,12 -0,01 -1723.71% | -0,16 -0,21 24.39% | -0,31 -0,21 -49.35% | -0,22 -0,29 23.22% | -0,08 -0,14 42.85% | -0,23 -0,23 -0.48% | -0,20 -0,24 17.26% | -0,28 -0,26 -6.92% | -0,10 -0,09 -13.53% | -0,30 | -0,27 | -0,28 | -0,08 | -0,26 |
| Announcement Date | 03/03/22 | 05/05/22 | 09/08/22 | 08/11/22 | 07/03/23 | 08/05/23 | 08/08/23 | 09/11/23 | 27/02/24 | - | - | - | - | - |
| 28/04/2024 | SHENZHEN YHLO BIOTECH CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 29/04/2024 | INARI MEDICAL, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | IRADIMED CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | NOVOCURE LIMITED: Q1 2024 Earnings Release |
| 05/05/2024 | SHOCKWAVE MEDICAL, INC.: Q1 2024 Earnings Release |
| 06/05/2024 21:09 | SI-BONE, INC.: Q1 2024 Earnings Release |
| 07/05/2024 21:05 | MASIMO CORPORATION: Q1 2024 Earnings Release |
| 07/05/2024 21:05 | TREACE MEDICAL CONCEPTS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 21:05 | PENUMBRA, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | CHEMOMETEC A/S: Q3 2024 Earnings Release |
Past sector events for Treace Medical Concepts, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TMCI Stock
- Calendar Treace Medical Concepts, Inc.
